Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Autologous bone marrow-derived mononuclear cell fraction

EU orphan designation number: EU/3/10/775   
Active ingredient: Autologous bone marrow-derived mononuclear cell fraction
Indication: Treatment of thromboangiitis obliterans (Buerger's disease)
Sponsor: t2cure GmbH
Kennedyallee 93, 60596 Frankfurt am Main, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/09/2010 Centralised Orphan - Designation EMA/OD/041/10 (2010)6642 of 20/09/2010
30/09/2013 Other procedure